FDA clears CathEffects' mapping system:
This article was originally published in Clinica
Executive Summary
CathEffects has received US clearance to market its cardiac electrophysiology mapping system for use with its previously FDA-cleared five-electrode two-plane mapping catheter (see Clinica No 978, p 17). The Desai VectorCath mapping system offers an economic product that reduces mapping time and improves accuracy," said Shawn Fojtik, the firm's COO. "The mapping system is inexpensive when compared to other systems, requires almost no procedure set-up time, and delivers instantaneous mapping data," Mr Fojtik added.